Increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, increasing awareness about the advancements in preparative and process chromatography, increasing food safety concerns, and growing government investments for synthetic biology and genome projects to drive the growth of the market during the forecast period. 

The COVID-19 pandemic has significantly affected the preparative and process chromatography market. With the increasing threat associated with COVID, researchers are highly dependent on analytical laboratory techniques such as chromatography to gain effective and efficient methods for characterizing the virus and analyze potential vaccines and anti-COVID-19 compounds. 

Chromatography is one of the essential technologies in this field, mainly in purifying biomolecules, including RNA. Analytical instruments play a central role in the laboratory work centering around the SARS-CoV-2 virus, including the three main areas of COVID-19-related research -- vaccine development, therapeutics development, and diagnostic testing. 

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151748164 

As the battle against the deadly SARS-CoV-2 virus continues, researchers rely on analytical laboratory techniques like chromatography to provide effective and efficient methods for characterizing the virus and analyzing potential vaccines and anti-COVID-19 compounds. 

The PREP 2020 is the longest-running & recognized international scientific conference and exposition driving the field of Preparative and Process Chromatography, organized by expert scientists and engineers for the separation science practitioner. The symposium addressed the latest scientific and technological advances, critical and emerging applications and processes, and challenges and solutions in all aspects of Preparative and Process Chromatography, Ion Exchange, Adsorption/Desorption Processes, and Related Separation Techniques. 

Preparative and process chromatography systems are priced at a premium because of the features and technologies involved. Small- & medium-sized companies in the oil & gas, food & beverage, biotech & pharmaceutical industries, and research and academic institutions require many such systems in their processes. Hence, the capital cost spent on these systems increases significantly. 

Due to the high costs involved and the budget constraints of many academic institutions, preparative and process chromatography products are witnessing limited adoption. Moreover, pharmaceutical companies currently using preparative and process chromatography are reluctant to invest in new instruments. 

Preparative and process chromatography plays a vital role in purifying monoclonal antibodies (mAbs). mAbs showcase enormous potential as biopharmaceuticals to treat a wide range of diseases. With such promising opportunities, major biopharmaceutical players such as Pfizer Inc. (US), Novartis International AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Amgen Inc. (US), and Samsung Bioepis (South Korea) have increased their focus on mAbs.